Cart
0

Nuclear Medicine Equipment Market by Product Type (SPECT and PET), Application (Neurology, Oncology, Cardiology, and Others), and End User (Hospitals, Imaging Centers, and Academic & Research Institutes) - Global Opportunity Analysis and Industry Forecast, 2014-2022

Get 20% Free Customization In This Report
LI_171828
Pages: 170
Feb 2017 | 2461 Views
 
Author's : Pallavi Jaiswal
Tables: 53
Charts: 40
 

Nuclear Medicine Equipment Market:

The global nuclear medicine equipment market was valued at $2,012 million in 2015, and is estimated to reach $2,647 million by 2022, growing at a CAGR of 3.9% during the forecast period. Nuclear medicine utilizes radionuclides, which are unstable atoms that emit radiation spontaneously, to examine and treat diseases such as, cancer, cardiovascular, and others.

Radionuclides are cleaned and compounded like other drugs to form radiopharmaceuticals. Nuclear medicine imaging offers information at the molecular and cellular level in the body with the help of uptake of radiotracers by the tissues.

Nuclear medicine equipment are used to diagnose and treat various diseases, such as cancer, cardiovascular diseases, neurological diseases, and for drug development. These equipment are used to examine/study different processes including metabolism, tissue blood flow, expression of cell receptors in normal and abnormal cells, neurotransmitter activity, homing, cell trafficking, and apoptosis. Equipment used for anatomic imaging are single-photon emission computed tomography (SPECT) and positron emission tomography (PET), enhance the accuracy of nuclear medicine imaging. These devices when combined with computed tomography (CT) (PET/CT and SPECT/CT devices) deliver better results in areas such as unidentifiable structural alteration.

The nuclear medicine equipment market is segmented based on product type, application, end user, and geography. Based on product, the market is divided into SPECT, which is further segmented into standalone, and hybrid SPECT, and PET is subcategorized as standalone and hybrid PET. By application, it is categorized into cardiology, neurology, oncology, and others (orthopedics, urology, thyroid-related disorders, and gastroenterology). Based on end user, it is segmented into hospitals, imaging centers, and academic & research institutes. Geographically, it is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, Russia, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, and rest of Asia-Pacific), and LAMEA (Brazil, Turkey, Saudi Arabia, Republic of South Africa, Argentina, and rest of LAMEA).

The market growth is driven by the emergence of latest and advanced products, development in clinics and centers for diagnostic imaging, advancement in radiotracers, and increase in number of patients with cancer and cardiac ailments. However, factors such as shorter half-life of radiopharmaceuticals and high cost of nuclear imaging equipment, coupled with unfavorable reimbursement initiatives, restrict market growth in developing regions.

Major players in the nuclear medicine equipment industry have adopted product launch as their key developmental strategy to expand their market foothold. For instance, in October 2016, Siemens Healthineers launched xSPECT Quant technology, which enables quantification of three additional isotopes using Symbia Intevoystem; this was a major evolution of SPECT/CT.

Key players profiled in this report are General Electric Company, Koninklijke Philips N.V., Siemens Aktiengesellschaft, Digirad Corporation, Mediso Medical Imaging Systems, Ltd., Toshiba Corporation, Bozlu Holding, Neusoft Corporation, Compañía Mexicana de Radiología CGR, S.A de C.V., and SurgicEye GmbH. Other players operating in this market include CMR Naviscan Corporation, DDD-Diagnostic A/S, Positron Corporation, and TeraRecon, Inc.

Asia-Pacific and LAMEA possess high market potential, owing to rise in prevalence of cancer and other chronic diseases, rising awareness about the early diagnosis of cancer, growth in demand for nuclear medicine equipment, and presence of untapped opportunities. For example, in Nepal, in June 2016, Sooriya Diagnostic installed its first Discovery IQ PET/CT scanner for early diagnosis of cancer, due to the growing cancer cases.

The nuclear medicine equipment market share in Argentina is projected to grow at a CAGR of 6.0% during the forecast period, as Argentina has the highest number of breast and colon cancer cases worldwide, which is expected to drive the market growth.

KEY BENEFITS FOR STAKEHOLDERS

  • This report provides a detailed quantitative analysis of the current nuclear medicine equipment market trends from 2014 to 2022 to identify the prevailing opportunities.
  • The market estimations are based on comprehensive analysis of the key developments in the nuclear medicine equipment industry.
  • The global nuclear medicine equipment industry is comprehensively analyzed with respect to product type, application, end user, and geography.
  • In-depth analysis of the market size based on geography helps in understanding the regional market to assist in strategic business planning.
  • The recent developments and strategies adopted by key manufacturers are enlisted to understand the competitive market scenario.

NUCLEAR MEDICINE EQUIPMENT MARKET KEY SEGMENTS

By Product

  • Single-Photon Emission Computed Tomography (SPECT)
    • Standalone
    • Hybrid
  • Positron Emission Tomography (PET)
    • Standalone
    • Hybrid

By Application

  • Neurology
  • Oncology
  • Cardiology
  • Others

By End User

  • Hospitals
  • Imaging Centers
  • Academic & Research Institutes

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Turkey
    • Saudi Arabia
    • Republic of South Africa
    • Argentina
    • Rest of LAMEA
 

Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top player positioning
3.2.3. Top winning strategies

3.3. GOVERNMENT REGULATIONS

3.3.1. U.S. FDA
3.3.2. Europe CE Mark
3.3.3. Ministry of Health, Labour, and Welfare (MHLW)

3.4. REIMBURSEMENT SCENARIOS
3.5. CLINICAL TRIALS
3.6. MARKET DYNAMICS

3.6.1. Drivers

3.6.1.1. Rise in prevalence of chronic diseases
3.6.1.2. Efficient and convenient technique
3.6.1.3. Increase in awareness about these equipment

3.6.2. Restraints

3.6.2.1. Budget constraints
3.6.2.2. Lack of trained professionals

3.6.3. Opportunities

3.6.3.1. Technological advancements
3.6.3.2. Requirement for skilled professionals

Chapter: 4 NUCLEAR MEDICINE EQUIPMENT MARKET, BY PRODUCT TYPE

4.1. OVERVIEW
4.2. MARKET SIZE AND FORECAST
4.3. SPECT

4.3.1. Key market trends
4.3.2. KCloseey growth factors and opportunities
4.3.3. Market size and forecast
4.3.4. Standalone SPECT

4.3.4.1. Market size and forecast

4.3.5. Hybrid SPECT

4.3.5.1. Market size and forecast

4.4. PET

4.4.1. Key market trends
4.4.2. Key growth factors and opportunities
4.4.3. Market size and forecast
4.4.4. Standalone PET

4.4.4.1. Market size and forecast

4.4.5. Hybrid PET

4.4.5.1. Market size and forecast

Chapter: 5 NUCLEAR MEDICINE EQUIPMENT MARKET, BY APPLICATION

5.1. OVERVIEW
5.2. MARKET SIZE AND FORECAST
5.3. NEUROLOGY

5.3.1. Market size and forecast

5.4. ONCOLOGY

5.4.1. Market size and forecast

5.5. CARDIOLOGY

5.5.1. Market size and forecast

5.6. OTHERS

5.6.1. Market size and forecast

Chapter: 6 NUCLEAR MEDICINE EQUIPMENT MARKET, BY END USER

6.1. OVERVIEW
6.2. MARKET SIZE AND FORECAST
6.3. HOSPITALS

6.3.1. Market size and forecast

6.4. IMAGING CENTERS

6.4.1. Market size and forecast

6.5. ACADEMIC & RESEARCH INSTITUTES

6.5.1. Market size and forecast

Chapter: 7 NUCLEAR MEDICINE EQUIPMENT MARKET, BY GEOGRAPHY

7.1. OVERVIEW
7.2. MARKET SIZE AND FORECAST
7.3. NORTH AMERICA

7.3.1. Key market trends
7.3.2. Key growth factors and opportunities
7.3.3. Market size and forecast
7.3.4. U.S.
7.3.5. Canada
7.3.6. Mexico

7.4. EUROPE

7.4.1. Key market trends
7.4.2. Key growth factors and opportunities
7.4.3. Market size and forecast
7.4.4. Germany
7.4.5. France
7.4.6. UK
7.4.7. Italy
7.4.8. Spain
7.4.9. Russia
7.4.10. Rest of Europe

7.5. ASIA-PACIFIC

7.5.1. Key market trends
7.5.2. Key growth factors and opportunities
7.5.3. Market size and forecast
7.5.4. Japan
7.5.5. China
7.5.6. Australia
7.5.7. India
7.5.8. Rest of Asia-Pacific

7.6. LAMEA

7.6.1. Key market trends
7.6.2. Key growth factors and opportunities
7.6.3. Market size and forecast
7.6.4. Brazil
7.6.5. Turkey
7.6.6. Saudi Arabia
7.6.7. Republic of South Africa
7.6.8. Argentina
7.6.9. Rest of LAMEA

Chapter: 8 COMPANY PROFILES

8.1. BOZLU HOLDING

8.1.1. Company overview
8.1.2. Key strategic moves and developments

8.2. COMPAÑÍA MEXICANA DE RADIOLOGÍA CGR, S.A. DE C.V.

8.2.1. Company overview

8.3. DIGIRAD CORPORATION

8.3.1. Company overview
8.3.2. Operating business segments
8.3.3. Business performance
8.3.4. Key strategic moves and developments

8.4. GENERAL ELECTRIC COMPANY

8.4.1. Company overview
8.4.2. Operating business segments
8.4.3. Business performance
8.4.4. Key strategic moves and developments

8.5. KONINKLIJKE PHILIPS N.V.

8.5.1. Company overview
8.5.2. Operating business segments
8.5.3. Business performance
8.5.4. Key strategic moves and developments

8.6. MEDISO MEDICAL IMAGING SYSTEMS, LTD.

8.6.1. Company overview
8.6.2. Operating business segments
8.6.3. Key strategic moves and developments

8.7. NEUSOFT CORPORATION

8.7.1. Company overview
8.7.2. Operating business segments
8.7.3. Key strategic moves and developments

8.8. SIEMENS AKTIENGESELLSCHAFT

8.8.1. Company overview
8.8.2. Operating business segments
8.8.3. Business performance
8.8.4. Key strategic moves and developments

8.9. SURGICEYE GMBH

8.9.1. Company overview
8.9.2. Key strategic moves and developments

8.10. TOSHIBA CORPORATION

8.10.1. Company overview
8.10.2. Operating business segments
8.10.3. Business performance

LIST OF TABLES

TABLE 1. CLINICAL TRIALS: NUCLEAR MEDICINE EQUIPMENT MARKET, 2010-2016
TABLE 2. GLOBAL NUCLEAR MEDICINE EQUIPMENT MARKET, BY PRODUCT TYPE,  2014-2022 ($MILLION)
TABLE 3. NUCLEAR MEDICINE EQUIPMENT MARKET FOR SPECT SYSTEMS,  BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 4. GLOBAL NUCLEAR MEDICINE EQUIPMENT MARKET FOR SPECT SYSTEMS,  BY TYPE, 2014-2022 ($MILLION)
TABLE 5. NUCLEAR MEDICINE EQUIPMENT MARKET FOR STANDALONE SPECT SYSTEMS, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 6. NUCLEAR MEDICINE EQUIPMENT MARKET FOR HYBRID SPECT SYSTEMS, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 7. NUCLEAR MEDICINE EQUIPMENT MARKET FOR PET SYSTEMS, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 8. NUCLEAR MEDICINE EQUIPMENT MARKET FOR PET SYSTEMS, BY TYPE,  2014-2022 ($MILLION)
TABLE 9. NUCLEAR MEDICINE EQUIPMENT MARKET FOR STANDALONE PET SYSTEMS,  BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 10. NUCLEAR MEDICINE EQUIPMENT MARKET FOR HYBRID PET SYSTEMS,  BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 11. GLOBAL NUCLEAR MEDICINE EQUIPMENT MARKET, BY APPLICATION,  2014-2022 ($MILLION)
TABLE 12. NUCLEAR MEDICINE EQUIPMENT MARKET FOR NEUROLOGY, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 13. NUCLEAR MEDICINE EQUIPMENT MARKET FOR ONCOLOGY, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 14. NUCLEAR MEDICINE EQUIPMENT MARKET FOR CARDIOLOGY, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 15. NUCLEAR MEDICINE EQUIPMENT MARKET FOR OTHER APPLICATIONS,  BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 16. GLOBAL NUCLEAR MEDICINE EQUIPMENT MARKET, BY END USER,  2014-2022 ($MILLION)
TABLE 17. NUCLEAR MEDICINE EQUIPMENT MARKET FOR HOSPITALS, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 18. NUCLEAR MEDICINE EQUIPMENT MARKET FOR IMAGING CENTERS,  BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 19. NUCLEAR MEDICINE EQUIPMENT MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 20. NUCLEAR MEDICINE EQUIPMENT MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 21. NORTH AMERICA NUCLEAR MEDICINE EQUIPMENT MARKET, BY PRODUCT TYPE, 2014-2022 ($MILLION)
TABLE 22. NORTH AMERICA NUCLEAR MEDICINE EQUIPMENT MARKET, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 23. NORTH AMERICA NUCLEAR MEDICINE EQUIPMENT MARKET, BY END USER, 2014-2022 ($MILLION)
TABLE 24. NORTH AMERICA NUCLEAR MEDICINE EQUIPMENT MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 25. EUROPE NUCLEAR MEDICINE EQUIPMENT MARKET, BY PRODUCT TYPE,  2014-2022 ($MILLION)
TABLE 26. EUROPE NUCLEAR MEDICINE EQUIPMENT MARKET, BY APPLICATION,  2014-2022 ($MILLION)
TABLE 27. EUROPE NUCLEAR MEDICINE EQUIPMENT MARKET, BY END USER,  2014-2022 ($MILLION)
TABLE 28. EUROPE NUCLEAR MEDICINE EQUIPMENT MARKET, BY COUNTRY,  2014-2022 ($MILLION)
TABLE 29. ASIA-PACIFIC NUCLEAR MEDICINE EQUIPMENT MARKET, BY PRODUCT TYPE, 2014-2022 ($MILLION)
TABLE 30. ASIA-PACIFIC NUCLEAR MEDICINE EQUIPMENT MARKET, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 31. ASIA-PACIFIC NUCLEAR MEDICINE EQUIPMENT MARKET, BY END USER,  2014-2022 ($MILLION)
TABLE 32. ASIA-PACIFIC NUCLEAR MEDICINE EQUIPMENT MARKET, BY COUNTRY,  2014-2022 ($MILLION)
TABLE 33. LAMEA NUCLEAR MEDICINE EQUIPMENT MARKET, BY PRODUCT TYPE,  2014-2022 ($MILLION)
TABLE 34. LAMEA NUCLEAR MEDICINE EQUIPMENT MARKET, BY APPLICATION,  2014-2022 ($MILLION)
TABLE 35. LAMEA NUCLEAR MEDICINE EQUIPMENT MARKET, BY END USER, 2014-2022 ($MILLION)
TABLE 36. LAMEA NUCLEAR MEDICINE EQUIPMENT MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 37. BOZLU HOLDING: COMPANY SNAPSHOT
TABLE 38. CMR: COMPANY SNAPSHOT
TABLE 39. DIGIRAD: COMPANY SNAPSHOT
TABLE 40. DIGIRAD: OPERATING SEGMENTS
TABLE 41. GE: COMPANY SNAPSHOT
TABLE 42. GE: OPERATING SEGMENTS
TABLE 43. PHILIPS: COMPANY SNAPSHOT
TABLE 44. PHILIPS: OPERATING SEGMENTS
TABLE 45. MEDISO: COMPANY SNAPSHOT
TABLE 46. MEDISO: OPERATING SEGMENTS
TABLE 47. NEUSOFT: COMPANY SNAPSHOT
TABLE 48. NEUSOFT: OPERATING SEGMENTS
TABLE 49. SIEMENS: COMPANY SNAPSHOT
TABLE 50. SIEMENS: OPERATING SEGMENTS
TABLE 51. SURGICEYE: COMPANY SNAPSHOT
TABLE 52. TOSHIBA: COMPANY SNAPSHOT
TABLE 53. TOSHIBA: OPERATING SEGMENTS

LIST OF FIGURES

FIGURE 1. SEGMENTATION
FIGURE 2. TOP INVESTMENT POCKETS: GLOBAL NUCLEAR MEDICINE EQUIPMENT MARKET, BY PRODUCT TYPE
FIGURE 3. TOP PLAYER POSITIONING OF NUCLEAR MEDICINE EQUIPMENT MARKET, 2015
FIGURE 4. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION (2013–2016)
FIGURE 5. NUCLEAR MEDICINE EQUIPMENT MARKET, BY GEOGRAPHY,  2014-2022 ($MILLION)
FIGURE 6. U.S. NUCLEAR MEDICINE EQUIPMENT MARKET, 2014-2022 ($MILLION)
FIGURE 7. CANADA NUCLEAR MEDICINE EQUIPMENT MARKET, 2014-2022 ($MILLION)
FIGURE 8. MEXICO NUCLEAR MEDICINE EQUIPMENT MARKET, 2014-2022 ($MILLION)
FIGURE 9. GERMANY NUCLEAR MEDICINE EQUIPMENT MARKET, 2014-2022 ($MILLION)
FIGURE 10. FRANCE NUCLEAR MEDICINE EQUIPMENT MARKET, 2014-2022 ($MILLION)
FIGURE 11. UK NUCLEAR MEDICINE EQUIPMENT MARKET, 2014-2022 ($MILLION)
FIGURE 12. ITALY NUCLEAR MEDICINE EQUIPMENT MARKET, 2014-2022 ($MILLION)
FIGURE 13. SPAIN NUCLEAR MEDICINE EQUIPMENT MARKET, 2014-2022 ($MILLION)
FIGURE 14. RUSSIA NUCLEAR MEDICINE EQUIPMENT MARKET, 2014-2022 ($MILLION)
FIGURE 15. REST OF EUROPE NUCLEAR MEDICINE EQUIPMENT MARKET,  2014-2022 ($MILLION)
FIGURE 16. JAPAN NUCLEAR MEDICINE EQUIPMENT MARKET, 2014-2022 ($MILLION)
FIGURE 17. CHINA NUCLEAR MEDICINE EQUIPMENT MARKET, 2014-2022 ($MILLION)
FIGURE 18. AUSTRALIA NUCLEAR MEDICINE EQUIPMENT MARKET, 2014-2022 ($MILLION)
FIGURE 19. INDIA NUCLEAR MEDICINE EQUIPMENT MARKET, 2014-2022 ($MILLION)
FIGURE 20. REST OF ASIA-PACIFIC NUCLEAR MEDICINE EQUIPMENT MARKET,  2014-2022 ($MILLION)
FIGURE 21. BRAZIL NUCLEAR MEDICINE EQUIPMENT MARKET, 2014-2022 ($MILLION)
FIGURE 22. TURKEY NUCLEAR MEDICINE EQUIPMENT MARKET, 2014-2022 ($MILLION)
FIGURE 23. SAUDI ARABIA NUCLEAR MEDICINE EQUIPMENT MARKET, 2014-2022 ($MILLION)
FIGURE 24. REPUBLIC OF SOUTH AFRICA NUCLEAR MEDICINE EQUIPMENT MARKET, 2014-2022 ($MILLION)
FIGURE 25. ARGENTINA NUCLEAR MEDICINE EQUIPMENT MARKET, 2014-2022 ($MILLION)
FIGURE 26. REST OF LAMEA NUCLEAR MEDICINE EQUIPMENT MARKET, 2014-2022 ($MILLION)
FIGURE 27. DIGIRAD CORPORATION: REVENUE BY YEAR ($MILLION)
FIGURE 28. DIGIRAD CORPORATION: REVENUE BY SEGMENT (%)
FIGURE 29. GE: REVENUE BY YEAR ($BILLION)
FIGURE 30. GE: REVENUE BY SEGMENT (%)
FIGURE 31. GE: REVENUE BY GEOGRAPHY (%)
FIGURE 32. PHILIPS: REVENUE BY YEAR ($MILLION)
FIGURE 33. PHILIPS: REVENUE BY SEGMENT, 2015 (%)
FIGURE 34. PHILIPS: REVENUE BY GEOGRAPHY, 2015 (%)
FIGURE 35. SIEMENS: REVENUE BY YEAR ($MILLION)
FIGURE 36. SIEMENS: REVENUE BY SEGMENT (%)
FIGURE 37. SIEMENS: REVENUE BY GEOGRAPHY, 2015 (%)
FIGURE 38. TOSHIBA: REVENUE BY YEAR ($MILLION)
FIGURE 39. TOSHIBA: REVENUE BY SEGMENT, 2015 (%)
FIGURE 40. TOSHIBA: REVENUE BY GEOGRAPHY, 2015 (%)

 

The market for nuclear medicine equipment is growing at a rapid pace owing to the advancements in technology, development of radiotracers, rise in prevalence of chronic diseases, and growth in awareness of the benefits of early diagnosis. Nuclear medicine equipment are widely used for the diagnosis and therapeutic assessment of diseases such as cancer, cardiovascular, and neurovascular disorders, as tools such as PET/CT provide highly detailed images of the tumor or diseased location. Cancer/oncology segment is expected to dominate the market as these equipment can easily differentiate between normal changes and tumor deterioration.

Hybrid PET installations have witnessed high growth in the recent past, as reimbursements for usage of PET/CT scans are provided to cancer patients with thyroid and cervical cancers and neurodegenerative diseases. However, facilities such as hospitals and imaging centers do not get any reimbursements for the procurement of these equipment. Owing to the advantages of nuclear medicine equipment, government and non-government agencies provide funding to the hospitals to install these equipment, further driving the market growth.

 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry
 

Request Sample

Request Customization

Request sample

OR

Purchase Full Report of
Nuclear Medicine Equipment Market- Global Opportunity Analysis and Industry Forecast, 2014-2022

  • Online Only
  • $4176
  • Online cloud Access only
  • Restricted Print, copy, paste,download
  • Read Only
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Data Pack
  • $4640
  • Restricted to one authorized users
  • One print only
  • Available in Excel
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Single User
  • $5540
  • Restricted to one authorized users
  • One print only
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Five User
  • $6654
  • Limited to 5 authorized users
  • Print Upto Five Copies
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Enterprise
    License/PDF

  • $9280
  • Unlimited within company/enterprise
  • Unlimited within company/enterprise
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Access reports on all emerging
market of Life Sciences on Knowledge Tree Platform
Free Demo